Baker Ellis Asset Management LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,139 filers reported holding NOVARTIS A G in Q4 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.

Quarter-by-quarter ownership
Baker Ellis Asset Management LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$1,300,651
-1.0%
12,769
-1.9%
0.23%
+4.9%
Q2 2023$1,313,748
+8.8%
13,019
-0.8%
0.22%
+3.2%
Q1 2023$1,206,949
-2.3%
13,119
-3.7%
0.22%
-9.6%
Q4 2022$1,235,516
+18.2%
13,619
-0.9%
0.24%
+4.8%
Q3 2022$1,045,000
-11.1%
13,742
-1.1%
0.23%
-6.6%
Q2 2022$1,175,000
-3.5%
13,895
+0.2%
0.24%
+11.9%
Q1 2022$1,217,000
+1.1%
13,869
+0.7%
0.22%
+2.8%
Q4 2021$1,204,000
+4.7%
13,769
-1.9%
0.21%
-4.5%
Q3 2021$1,150,000
-13.1%
14,029
-3.3%
0.22%
-14.3%
Q2 2021$1,324,000
-13.0%
14,508
-18.5%
0.26%
-21.3%
Q1 2021$1,522,000
-14.0%
17,809
-4.9%
0.33%
-22.0%
Q4 2020$1,769,000
+7.6%
18,729
-1.0%
0.42%
-8.1%
Q3 2020$1,644,000
-2.4%
18,909
-2.0%
0.46%
-7.6%
Q2 2020$1,685,000
+3.5%
19,291
-2.3%
0.50%
-14.8%
Q1 2020$1,628,000
-20.9%
19,741
-9.2%
0.58%
+2.5%
Q4 2019$2,059,000
+6.1%
21,741
-2.7%
0.57%
+10.3%
Q3 2019$1,941,000
-13.9%
22,341
-9.5%
0.52%
-13.9%
Q2 2019$2,254,000
-8.6%
24,681
-3.8%
0.60%
-12.8%
Q1 2019$2,467,000
+8.6%
25,656
-3.1%
0.69%
-0.3%
Q4 2018$2,272,000
-3.5%
26,481
-3.1%
0.69%
+13.7%
Q3 2018$2,354,000
-17.5%
27,321
-27.7%
0.61%
-19.2%
Q2 2018$2,853,000
-18.7%
37,766
-13.0%
0.75%
-18.6%
Q1 2018$3,509,000
-5.2%
43,404
-1.6%
0.92%
-1.2%
Q4 2017$3,702,000
-1.1%
44,094
+1.1%
0.93%
-6.1%
Q3 2017$3,743,000
+1.6%
43,594
-1.2%
0.99%
-1.7%
Q2 2017$3,685,000
+16.0%
44,144
+3.2%
1.01%
+11.2%
Q1 2017$3,178,000
+1.7%
42,794
-0.2%
0.91%
-1.0%
Q4 2016$3,124,000
-7.1%
42,894
+0.8%
0.92%
-9.6%
Q3 2016$3,362,000
-4.0%
42,574
+0.3%
1.01%
-7.7%
Q2 2016$3,503,000
+16.0%
42,450
+1.8%
1.10%
+10.2%
Q1 2016$3,021,000
-15.8%
41,700
+0.0%
1.00%
-19.0%
Q4 2015$3,586,000
-6.1%
41,681
+0.4%
1.23%
-9.6%
Q3 2015$3,818,000
-6.3%
41,531
+0.2%
1.36%
-0.5%
Q2 2015$4,076,000
-6.3%
41,447
-6.0%
1.37%
-1.0%
Q1 2015$4,349,000
+5.6%
44,099
-0.8%
1.38%
-0.1%
Q4 2014$4,119,000
-2.4%
44,456
-0.9%
1.38%
-5.3%
Q3 2014$4,222,000
+4.0%
44,8560.0%1.46%
+5.6%
Q2 2014$4,061,000
+3.1%
44,856
-3.2%
1.38%
+1.5%
Q1 2014$3,940,000
+0.5%
46,339
-5.0%
1.36%0.0%
Q4 2013$3,919,000
+3.4%
48,756
-1.3%
1.36%
-4.6%
Q3 2013$3,789,000
+7.8%
49,391
-0.6%
1.43%
+2.4%
Q2 2013$3,515,00049,7131.40%
Other shareholders
NOVARTIS A G shareholders Q4 2021
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders